MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Parkinson’s Disease and Chronic Inflammatory Demyelinating Polyneuropathy: Broadening the Clinical Spectrum of VCP Mutations?

    E. Contaldi, L. Magistrelli, R. Cantello, S. Gallo, F. Vignaroli (Novara, Italy)

  • Parkinson’s Disease Hospital Optimization Project

    B. Valdovinos, K. Amodeo, E. Kanouse, A. Chesire, J. Lowell, M. Braun, N. Chunga, D. Ruebeck, A. Macikowski, V. Basic, M. Deweese, E. Hufziger, J. Hayes, A. Skuse, I. Richard (Rochester, USA)

  • Parkinson’s disease in patients with Gaucher’s disease – causation or association?

    B. Pandey (Tirupati, India)

  • Parkinson’s disease management in the community

    L. Ambrosio, MV. Navarta, D. Kunkel, A. Pedraz-Marcos, A. Palmar-Santos, A. Haahr, LB. Vester, LK. Bragstad, TL. Nielsen, NB. Kruse, EG. Hjelle, SB. Haavaag, MC. Portillo (Southampton, United Kingdom)

  • Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease

    V. Stopic, S. Jost, JC. Baldermann, JN. Petry-Schmelzer, G. Fink, T. Dembek, H. Dafsari, J. Kessler, M. Barbe, A. Sauerbier (Cologne, Germany)

  • Parkinson’s disease-specific cortical atrophy as an independent contributor to motor symptom in Parkinson’s disease

    SW. Kang, HS. Yoo, CL. Lyoo (Seoul, Republic of Korea)

  • Parkinson’s Progression Markers Initiative (PPMI) prioritizes enrollment of individuals from diverse and underrepresented populations

    R. Dobkin, M. Kutler, A. O'Grady, C. Kelliher, K. Greenwood, M. Kuhl, S. Fong, S. Mantri (Piscataway, USA)

  • Parkinson’s Progression Markers Initiative (PPMI): Defining PD biology to accelerate PD therapeutics

    B. Mcmahon, A. Siderowf, T. Simuni, C. Tanner, B. Mollenhauer, C. Coffey, D. Galasko, K. Posten, L. Chahine, R. Dobkin, T. Froud, K. Kieburtz, D. Weintraub, K. Merchant, M. Frasier, T. Sherer, S. Chowdhury, E. Brown, R. Alcalay, A. Videnovic, K. Fabrizio, E. Flagg, K. Marek (New Haven, USA)

  • Parkinsonian tremor secondary to Sinking flap syndrome – An atypical presentation

    R. Kota, K. Garg, M. Singh, R. Rajan (NEW DELHI, India)

  • Parkinsonism and dilated ventricles: not all hydrocephalus is normal-pressure

    D. Tang, J. Vijayan, CH. Tan, SF. Woo, JH. Tan (Singapore, Singapore)

  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 186
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley